Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The RealReal heads into its November 3 earnings with short interest stubbornly elevated, insiders having sold in August, and options traders tilting more cautious than they were just weeks ago.
Short sellers are not backing down. At 13.9% of free float, short interest is one of the more crowded positions in the apparel retail space, and the past month has seen it climb roughly 13%. The week itself brought a slight 0.8% reduction in shares short, a modest covering that has done little to change the broader picture. The ORTEX short score sits at 57, which places the stock in the lower third of its universe on the short-score rank, meaning bearish positioning here is relatively well-established compared to peers. What's notable is the disconnect from the lending market: availability is loose at over 1,200% of short interest, with borrowing costs running well below 0.6%. There is no squeeze pressure. Shorts can add to or maintain positions without meaningful friction, and the data shows they have been doing exactly that since early September, when shares short jumped by roughly 2 million in the space of a week.
Options positioning has shifted noticeably more cautious over the past month. The put/call ratio is running at 0.44, above its 20-day average of 0.34. That's not an extreme reading, the 52-week high is 1.47, but the direction of travel matters. Through August and the first half of September, the PCR sat below 0.25. It has since nearly doubled, reflecting growing demand for downside protection as the November print approaches.
The Street sits in a split holding pattern. BTIG has maintained its Buy with a $17 target since at least May, while UBS sits at Neutral and raised its target from $14 to $16 after the August results. The mean target of $18 implies roughly 91% upside from the current $9.40, a wide gap that reflects the stock's sharp year-to-date decline rather than any genuine analyst consensus on near-term recovery. The bull case centres on record active buyer numbers (over 1 million for the first time), 17% revenue growth, and EBITDA margin expansion. The bear case points to consignor-base headwinds, the risk that luxury spending softens further, and competition from platforms that skip authentication entirely. Factor scores add texture: EPS momentum over 30 and 90 days ranks in the 90th and 97th percentiles respectively, and the EPS surprise score is near the top of the universe at the 98th percentile. The PE multiple has compressed about 4 points over the past 30 days, now at roughly 38x trailing earnings on a stock that is still burning through book value.
Insider activity from August is worth noting even six weeks later. The CEO, CFO, and Chief Accounting Officer all sold shares on August 21, the day after the Q2 results, at prices around $10.97 to $10.98. None of the trades were flagged as being made under a pre-arranged 10b5-1 plan. The combined net selling over the 90 days to September 30 came to roughly 173,000 shares at a net value of around $1.9 million. The stock is now trading nearly 15% below those August sale prices. Separately, the activist register carries a 13D from David Kanen, who has reduced his stake from 5.8% to 3.9% as of January 2025. Kanen's most recent amendment shows a falling position, and as the disclosure notes, holders who drop below 5% may exit without further filings. Divisadero Street Capital entered the register in June at 7.6%, making it the second-largest institutional holder behind BlackRock, which has been adding and now holds 9.4%.
The last two earnings prints provide useful context for what November might bring. After Q2 results in August, the stock fell 2.8% on the day and shed a further 14% over the following five days. The prior print in May produced a 1% gain on the day but a 5.8% decline over five sessions. Both outcomes suggest post-earnings drift has been consistently negative, with the magnitude depending on the specific details of the quarter. With the next report 26 days away, the combination of persistent short interest, tightening options, insider selling at prices above the current level, and an activist trimming all point to a stock where the focus will be squarely on whether the active-buyer momentum translates into improving financial trajectories rather than just headline KPI records.
See the live data behind this article on ORTEX.
Open REAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
